380 related articles for article (PubMed ID: 17667551)
1. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
Volante M; Collini P; Nikiforov YE; Sakamoto A; Kakudo K; Katoh R; Lloyd RV; LiVolsi VA; Papotti M; Sobrinho-Simoes M; Bussolati G; Rosai J
Am J Surg Pathol; 2007 Aug; 31(8):1256-64. PubMed ID: 17667551
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopic study of two cases.
Albores-Saavedra J; Sharma S
Mod Pathol; 2001 Feb; 14(2):98-104. PubMed ID: 11235911
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid carcinoma: a cytologic-histologic review.
Bongiovanni M; Sadow PM; Faquin WC
Adv Anat Pathol; 2009 Sep; 16(5):283-9. PubMed ID: 19700938
[TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.
Asioli S; Erickson LA; Righi A; Jin L; Volante M; Jenkins S; Papotti M; Bussolati G; Lloyd RV
Mod Pathol; 2010 Sep; 23(9):1269-78. PubMed ID: 20562850
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated thyroid carcinoma.
Xu B; Ghossein R
Semin Diagn Pathol; 2020 Sep; 37(5):243-247. PubMed ID: 32360274
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
9. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
Wang SL; Li SH; Chen WT; Chai CY
APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
[TBL] [Abstract][Full Text] [Related]
10. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
11. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Kim YW; Do IG; Park YK
Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
[TBL] [Abstract][Full Text] [Related]
12. The concepts in poorly differentiated carcinoma of the thyroid: a review article.
Nambiar A; Pv S; Susheelan V; Kuriakose MA
J Surg Oncol; 2011 Jun; 103(8):818-21. PubMed ID: 21283991
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features.
Gnemmi V; Renaud F; Do Cao C; Salleron J; Lion G; Wemeau JL; Copin MC; Carnaille B; Leteurtre E; Pattou F; Aubert S
Histopathology; 2014 Jan; 64(2):263-73. PubMed ID: 24164362
[TBL] [Abstract][Full Text] [Related]
14. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
Elsheikh TM; Asa SL; Chan JK; DeLellis RA; Heffess CS; LiVolsi VA; Wenig BM
Am J Clin Pathol; 2008 Nov; 130(5):736-44. PubMed ID: 18854266
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
16. [Problem areas of tumour classifications--thyroid carcinomas].
Schmid KW
Verh Dtsch Ges Pathol; 2007; 91():57-65. PubMed ID: 18314596
[TBL] [Abstract][Full Text] [Related]
17. [Poorly-differentiated thyroid carcinoma: morphological verification and differential diagnosis].
Friedman MV
Vopr Onkol; 2006; 52(1):47-53. PubMed ID: 16715703
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid carcinoma--differentiated, poorly differentiated and anaplastic carcinoma].
Kakudo K; Bai Y; Li Y; Wakasa T; Mori I
Nihon Rinsho; 2007 Nov; 65(11):1979-84. PubMed ID: 18018558
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for proliferative thyroid lesions in bony fishes.
Fournie JW; Wolfe MJ; Wolf JC; Courtney LA; Johnson RD; Hawkins WE
Toxicol Pathol; 2005; 33(5):540-51. PubMed ID: 16076769
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
Dettmer M; Schmitt A; Steinert H; Moch H; Komminoth P; Perren A
Histopathology; 2012 Jun; 60(7):1045-51. PubMed ID: 22348590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
